Founded in 2005 and headquartered in Beijing, Med-Zenith is an innovative medical device manufacturer specializing in three core cardiovascular disorder segments: congenital heart disease (CHD), valvular heart disease (VHD), and atrial fibrillation (AF). Centered on unmet clinical demands, the company develops high-performance equipment and premium implantable medical devices, delivering comprehensive interventional and surgical treatment solutions for cardiologists and cardiovascular patients.
About Med-zenith
Why Med-zenith
-
Insisting on Design Innovation
The company owns over 200 patents, including more than 60 invention patents and overseas PCT patents, continuously constructing a global intellectual property barrier for its proprietary technologies.
-
Technical and Quality Strength
It has undertaken national key R&D projects under the 12th and 13th Five-Year Plans (2011–2015, 2016–2020), alongside seven key municipal R&D programs funded by the Beijing Municipal Science and Technology Commission, demonstrating sustained strengths in innovative R&D and clinical translational research.seeking excellent technical partners in various fields and jointly developing more competitive products
-
Certifications
The enterprise holds certifications as a National High and New Technology Enterprise and Zhongguancun High-Tech Enterprise, operates a Postdoctoral Research Station accredited by the Ministry of Human Resources and Social Security (MOHRSS), and ranks among Beijing’s first cohort of G20 Key Biomedical Enterprises.
-
Brand Flagship Stores
It was named a Zhongguancun Gazelle Enterprise in 2018, and awarded the national “Specialized, Refined, Unique and Innovative (SRUI) Little Giant” Enterprise title by the Ministry of Industry and Information Technology in 2021.
Patient Experience
-
Patients with atrial fibrillation may immediately resume sinus rhythm after ablation surgery. However, due to issues such as edema and scarring at the ablation site, atrial fibrillation may recur within six months postoperatively. It is only after six months that the effectiveness of atrial fibrillation treatment can be evaluated. Patients must adhere to prescribed medications, such as amiodarone.
Will the heart rhythm immediately return to normal after atrial fibrillation surgery?
-
The existing MAZE procedure for atrial fibrillation has matured over 30 years of development. The success rate of converting patients with paroxysmal, persistent, and permanent atrial fibrillation to sinus rhythm post-surgery varies slightly. Studies report a one-year conversion rate of 70-90%.
What is the success rate of converting atrial fibrillation to sinus rhythm in the operating room?
-
The therapeutic focus of the two differs: the goal of atrial fibrillation ablation is to eliminate ectopic pacemakers and block reentry circuits by applying techniques such as radiofrequency or cryoablation, thereby treating atrial fibrillation and restoring sinus rhythm.
Can atrial fibrillation ablation and left atrial appendage clipping be performed simultaneously?
-
Patients who have undergone the implantation of ear clips and pulmonary artery stents need to regularly undergo cardiac ultrasound and other necessary examinations according to medical advice. After surgery, patients should maintain a scientific lifestyle and behavioral habits, refrain from vigorous exercise for half a month, quit smoking, limit alcohol consumption, have a light diet, exercise appropriately, and adhere to taking medication on time. Self observation and regular follow-up examinations are necessary. If there is any discomfort, please contact your doctor.
What are the precautions after implanting a heart ear clip and pulmonary artery stent?
